Worldwide: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

FDA Continues Its Food Dye Cleanup

On July 22, 2026, the Food and Drug Administration (FDA) announced two additional steps in its ongoing effort to phase out petroleum-based color additives from the U.S. food supply.

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Ohio Expands Law On Use And Delegation Of Laser Hair Removal Devices

Effective August 25, 2026, Ohio House Bill 377 will revise the law governing light-based medical devices used for hair removal. The law modifies physician delegation standards related to hair removal lasers and creates specific provisions for advanced practice registered nurse and physician assistant delegation.

United States Healthcare

DS

Dinsmore & Shohl

Ohio Board Of Pharmacy Proposes Strengthened Disciplinary Actions: What Pharmacies Need To Know

The landscape of pharmacy regulation in Ohio continues to evolve, and pharmacies licensed in the state should pay close attention to the Ohio State Board of Pharmacy’s latest proposed rulemaking. On July 1, 2026...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

What To Watch: Forthcoming Limitation On DTC Pharmaceutical Ads

This month, the U.S. Food & Drug Administration (“FDA”) quietly published its Unified Agenda, which includes a proposed rulemaking that — if finalized — would fundamentally reshape the landscape...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Nevada’s Proposed New Regulations: What Pharmacies Need To Know

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Preparing For The Pharma Fraud Enforcement Surge

United States Healthcare

BT

Barnes & Thornburg LLP

Building The Next Generation Of Behavioral Health Platforms

United States Healthcare

SR

McDermott Will & Schulte

CMS Turns Up The Heat With Sweeping New Enrollment Enforcement Tools In HH PPS Proposed Rule

United States Healthcare

SR

McDermott Will & Schulte

Part III: Taking Buy Local To The Next Level: Supply Chain Developments In Life Sciences

United States Healthcare

AP

Arnold & Porter

FDA Emphasizes Totality-of-the-evidence Approach In Revised “substantial Evidence” Draft Guidance For Drugs, Biologics

United States Healthcare

HL

Hogan Lovells Cadwalader

Updated MOU Between USDA, HHS, And EPA Addresses Drug Residues, Pesticide Residues, And Chemical Contaminants In Food

United States Healthcare

BC

Bergeson & Campbell

TEFCA Expansion Signals Heightened Federal Scrutiny Of Health Information Sharing

United States Healthcare

BS

Bond, Schoeneck & King PLLC

Royalty Reductions Are Becoming More Expansive

United States Healthcare

GP

Goodwin Procter LLP

Commentary: A Physician's Perspective On Medicare Physician Payment Reform

United States Healthcare

HK

Holland & Knight

New Jersey High Court Highlights D&O Insurance Traps For Complex Business Structures

United States Insurance

KG

K&L Gates LLP

Supreme Court Immigration Update: Border Asylum Access, TPS For Haiti And Syria, And Employer Next Steps

United States Immigration

FL

Fennemore

DOJ Argues For Executive Control Over Citizen Suits, Seeking Seismic Changes To Environmental Law Enforcement

United States Environment

BD

Beveridge & Diamond

2026 AGA Annual Meeting Wrap-Up: State AGs Focus on AI, Privacy, Pricing, Child Safety, and Public-Private Partnerships

United States Commercial

KD

Kelley Drye & Warren LLP

Massachusetts Appeals Court Rejects Website Links As Sufficient Securities Disclosure Under State Law

United States Commercial

GT

Greenberg Traurig, LLP

See more

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Life Sciences, Biotechnology & Nanotechnology

Ohio Board Of Pharmacy Proposes Strengthened Disciplinary Actions: What Pharmacies Need To Know

The landscape of pharmacy regulation in Ohio continues to evolve, and pharmacies licensed in the state should pay close attention to the Ohio State Board of Pharmacy’s latest proposed rulemaking. On July 1, 2026...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

What To Watch: Forthcoming Limitation On DTC Pharmaceutical Ads

This month, the U.S. Food & Drug Administration (“FDA”) quietly published its Unified Agenda, which includes a proposed rulemaking that — if finalized — would fundamentally reshape the landscape...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

Nevada’s Proposed New Regulations: What Pharmacies Need To Know

Nevada pharmacies, physicians, healthcare facilities and other practitioners engaged in pharmaceutical compounding should closely monitor a significant regulatory proposal issued by the Nevada State Board of Pharmacy.

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

When Alleged Loss Is Delayed Or Tracks The Market, The United States Court Of Appeals For The Second Circuit Holds That Private Securities Plaintiffs Must Plead More To Survive Dismissal

United States Litigation

KL

Herbert Smith Freehills Kramer LLP

Is The 4th Time A Charm? Congress Revisits Patent Eligibility Reform

United States IP

HK

Holland & Knight

House Bill Would Establish Dedicated Biotechnology Official In State Department

United States Government

BC

Bergeson & Campbell

OECD Tour de Table Includes Information On TSCA Developments Regarding Nanomaterials

United States Environment

BC

Bergeson & Campbell

The UPC’s Growing Role In COVID Patent Disputes

United States IP

JA

J A Kemp LLP

Is Your Company IPO-Ready? The 12-Month Checklist

United States IP

FL

Foley & Lardner

See more

Healthcare

Ohio Expands Law On Use And Delegation Of Laser Hair Removal Devices

Effective August 25, 2026, Ohio House Bill 377 will revise the law governing light-based medical devices used for hair removal. The law modifies physician delegation standards related to hair removal lasers and creates specific provisions for advanced practice registered nurse and physician assistant delegation.

United States Healthcare

DS

Dinsmore & Shohl

Long-Term Care Facilities Face New Electronic Monitoring Rules In Illinois — What You Need To Know

For years, long-term care providers have navigated the delicate balance between respecting resident privacy, accommodating family oversight, honoring roommate privacy, and maintaining smooth facility operations.

United States Privacy

BI

Buchanan Ingersoll & Rooney PC

New ERISA Proposed Electronic Disclosure Rule

The U.S. Department of Labor's Employee Benefits Security Administration has issued a proposed electronic disclosure rule that would modernize how ERISA-governed group health plans deliver required documents to participants.

United States Employment

WT

Winston Taylor

DOL Proposes Electronic Disclosure Safe Harbor For Health Plan Documents

United States Employment

MB

Mayer Brown

The 2025 To 2026 PAGA Trend Update | 2 Years Out From The 2024 Reform, Where Are PAGA Filings Headed?

United States Government

AC

Ankura Consulting Group LLC

Florida Attorney General Opens Investigation Into PBM And Pharmacy Parent Company Over Alleged Anticompetitive Pharmacy Practices

United States Anti-trust

DM

Duane Morris LLP

CMS Issues Proposed Guidance Governing Maximum Fair Price Effectuation For IPAY 2028, With A Focus On Part B Drugs

United States Finance

HL

Hogan Lovells Cadwalader

Nevada’s Proposed New Regulations: What Pharmacies Need To Know

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

FTC Prescribes Lower Out-of-Pocket Insulin Costs In Settlement With Caremark

United States Anti-trust

AV

Axinn

See more

Food and Drugs Law

FDA Continues Its Food Dye Cleanup

On July 22, 2026, the Food and Drug Administration (FDA) announced two additional steps in its ongoing effort to phase out petroleum-based color additives from the U.S. food supply.

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Ohio Board Of Pharmacy Proposes Strengthened Disciplinary Actions: What Pharmacies Need To Know

The landscape of pharmacy regulation in Ohio continues to evolve, and pharmacies licensed in the state should pay close attention to the Ohio State Board of Pharmacy’s latest proposed rulemaking. On July 1, 2026...

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

What To Watch: Forthcoming Limitation On DTC Pharmaceutical Ads

This month, the U.S. Food & Drug Administration (“FDA”) quietly published its Unified Agenda, which includes a proposed rulemaking that — if finalized — would fundamentally reshape the landscape...

United States Healthcare

SM

Sheppard, Mullin, Richter & Hampton LLP

FTC Prescribes Lower Out-of-Pocket Insulin Costs In Settlement With Caremark

United States Anti-trust

AV

Axinn

When Alleged Loss Is Delayed Or Tracks The Market, The United States Court Of Appeals For The Second Circuit Holds That Private Securities Plaintiffs Must Plead More To Survive Dismissal

United States Litigation

KL

Herbert Smith Freehills Kramer LLP

Holland & Knight Health Dose: July 21, 2026

United States Government

HK

Holland & Knight

FDA Emphasizes Totality-of-the-evidence Approach In Revised “substantial Evidence” Draft Guidance For Drugs, Biologics

United States Healthcare

HL

Hogan Lovells Cadwalader

Updated MOU Between USDA, HHS, And EPA Addresses Drug Residues, Pesticide Residues, And Chemical Contaminants In Food

United States Healthcare

BC

Bergeson & Campbell

Practical Guidance For Pharmaceutical Method-of-Use Patent Claims After Teva v. Eli Lilly And In Re Xencor

United States IP

FL

Foley & Lardner

See more

Latest Videos

See more

StairAssist Walker (Video)

GU

Gesmer Updegrove LLP

A Guide To Plaintiffs Litigation Playbook: Litigation Trends And Hot Topics Surrounding Medical Devices And Emerging Technologies

AP

Arnold & Porter

No Foolin’: Business In 2026 Webinar Gets An April Makeover (Video)

BS

Bond, Schoeneck & King PLLC

PBM Reform 2026: What Recent Legislation Means For The Industry (Video)

M

Mintz

In The Know: The Clean Beauty Trend Becomes State Law (Video)

LL

Loeb & Loeb LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More